← Can-Fite BioPharma Ltd.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $165k |
$789k
+378.18%
|
$3.8m
+384.16%
|
$2.0m
-46.81%
|
$763k
-62.45%
|
$853k
+11.80%
|
$810k
-5.04%
|
$743k
-8.27%
|
$674k
-9.29%
|
$405k
-39.91%
|
$405k
0.00%
|
|
| Interest Income (Expense), Net | — | — | — | — | ($303k) |
$227k
+174.92%
|
($77k)
-133.92%
|
— | — | — | $284k | |
| Research and Development Expense | $6.1m | $5.1m | $6.1m | $11.0m | $12.0m | $9.8m | $7.8m | $6.0m | $5.8m | $6.7m | $6.7m | |
| Selling, General and Administrative Expense | $2.7m | $2.9m | $3.2m | $3.1m | — | — | $263k | — | — | — | $3.7m | |
| Other General and Administrative Expense | — | — | — | — | $158k | $198k | $126k | — | — | — | — | |
| General and administrative expenses | $10.5m | $3.0m | $3.2m | ($3.1m) | ($3.0m) | ($3.8m) | ($3.1m) | ($3.0m) | $3.0m | ($3.7m) | $3.7m | |
| Operating Expenses | — | — | — | — | — | — | $10.9m | $8.9m | $8.8m | $10.4m | $10.4m | |
| Operating Income (Loss) | $33.2m |
$7.4m
-77.74%
|
$5.4m
-26.78%
|
($12.0m)
-321.78%
|
($14.1m)
-17.76%
|
($12.8m)
+9.17%
|
($10.1m)
+21.38%
|
($8.2m)
+18.83%
|
($8.1m)
+0.79%
|
($9.9m)
-22.39%
|
($9.9m)
0.00%
|
|
| Investment Income, Net | — | — | — | — | — | — | — | — | — | $122k | — | |
| Gain (Loss) on Investments | — | — | — | — | $11k | $162k | — | — | — | — | — | |
| Other Nonoperating Income (Expense) | — | — | — | — | — | — | — | $561k | — | — | — | |
| Other Expenses | — | — | — | $690k | — | $4k | — | — | — | — | — | |
| Interest Expense (non-operating) | — | — | — | — | — | — | — | — | ($291k) | $284k | — | |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | $136k |
$94k
-30.88%
|
$6.6m
+6890.43%
|
($12.6m) | ($14.4m) | ($12.6m) | ($10.2m) | ($7.6m) | ($7.9m) | ($9.8m) | ($9.8m) | |
| Income Tax Expense Continuing Operations | $29k | $29k | $4k | — | — | — | — | — | — | — | $0 | |
| Net loss | $27.0m | $5.0m | $6.6m | ($9.6m) | ($14.4m) | ($12.6m) | ($10.2m) | ($7.6m) | ($7.9m) | ($9.8m) | — | |
| Net Income (Loss) Attributable to Parent | $136k |
$94k
-30.88%
|
$6.6m
+6890.43%
|
($12.6m)
-292.13%
|
($14.4m)
-14.40%
|
($12.6m)
+12.66%
|
($10.2m)
+19.36%
|
($7.6m)
+24.96%
|
($7.9m)
-3.22%
|
($9.8m)
-24.72%
|
($9.8m)
0.00%
|
|
| Earnings Per Share, Basic | $0.96 | $0.15 | $0.17 | ($0.11) | ($0.04) | ($0.03) | ($0.01) | ($0.01) | $0.00 | ($5.97) | ($10.75) | |
| Earnings Per Share, Diluted | $0.96 | $0.15 | $0.17 | ($0.11) | ($0.04) | ($0.03) | ($0.01) | ($0.01) | $0.00 | ($5.97) | ($10.75) | |
| Weighted Average Number of Shares Outstanding, Basic | — | — | — | — | — | — | 815.7m | 1.3b | 2.2b | 1.6m | 915k | |
| Weighted Average Number of Shares Outstanding, Diluted | — | — | — | — | — | — | 815.7m | 1.3b | 2.2b | 1.6m | 915k | |
| Additional Financial Items | ||||||||||||
| Administrative Expense | $6.1m | $5.1m | $6.1m | $11.0m | $12.0m | $9.8m | $7.8m | $6.0m | $5.8m | $6.7m | — | |
| Finance Costs | ($55k) | ($621k) | $1.2m | $693k | — | — | — | — | — | — | — | |
| Finance Income | ($374k) | ($633k) | $51k | $3.1m | — | — | — | — | — | — | — | |
| Postemployment Benefit Expense Defined Benefit Plans | $12k | — | — | $8k | — | — | — | — | — | — | — | |
| Professional Fees Expense | $1.0m | $1.1m | $1.2m | $1.2m | — | — | — | — | — | — | — | |
| Profit Loss Attributable To Noncontrolling Interests | $136k | $94k | — | — | — | — | — | — | — | — | — | |
| Profit Loss Attributable To Owners Of Parent | $8.3m | $6.3m | $6.6m | ($9.6m) | — | — | — | — | — | — | — | |
| Profit Loss Before Tax | ($8.4m) | ($6.4m) | ($6.6m) | ($9.6m) | — | — | — | — | — | — | — | |
| Profit Loss From Operating Activities | ($8.7m) | ($7.2m) | ($5.4m) | ($12.0m) | — | — | — | — | — | — | — | |
| Loss before taxes on income, Amount | — | — | ($6.6m) | ($12.6m) | ($14.4m) | ($12.6m) | ($10.2m) | ($7.6m) | ($7.9m) | ($9.8m) | — | |
| Net Foreign Exchange Loss | $16k | $588k | $115k | $28k | — | — | — | — | — | — | — | |
| Total financial income, net | ($6.3m) | ($1.9m) | — | — | — | — | — | $561k | $250k | $122k | — |